RCI's target audience is sophisticated and niche. It primarily consists of other businesses and institutions operating at the forefront of scientific and technological innovation. This includes clients within the pharmaceutical and biotech industries looking for drug discovery and development support, advanced materials companies seeking novel properties or manufacturing processes, and potentially academic or government research organizations requiring specialized R&D services or intellectual property development. The audience is not the general public; rather, it is comprised of highly specialized professionals and organizations with specific research and development needs that cannot be met by off-the-shelf solutions. They are likely seeking partnership opportunities for complex, long-term projects rather than transactional services.